Keywords: bayer, regeneron, expand, vegf, trap-eye, trial, program
Bayer and Regeneron expand VEGF Trap-Eye trial program to include CRVO
Article | 07 May 2009
Germany's Bayer HealthCare AG and the USA's Regeneron Pharmaceuticals have extended their development program for VEGF Trap-Eye, an investigational new ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
